{"count": 20, "results": [{"_id": "36367620", "pmid": 36367620, "pmcid": "PMC9928804", "title": "Simvastatin Induces Apoptosis And Suppresses Hepatocellular Carcinoma Induced In Rats", "journal": "Appl Biochem Biotechnol", "authors": ["Elleithi YA", "El-Gayar AM", "Amin MN"], "date": "2023-03-01T00:00:00Z", "doi": "10.1007/s12010-022-04203-0", "meta_date_publication": "2023 Mar", "meta_volume": "195", "meta_issue": "3", "meta_pages": "1656-1674", "score": 50266.62, "text_hl": "Apoptosis was assessed using immunohistochemistry (IHC) and quantitative PCR (qPCR). @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ was found to induce apoptosis successfully in @DISEASE_Carcinoma_Hepatocellular @DISEASE_MESH:D006528 @@@HCC@@@ and improve @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver fibrosis@@@, overall hepatic function, and necroinflammatory score. ", "citations": {"NLM": "Elleithi YA, El-Gayar AM, Amin MN. Simvastatin Induces Apoptosis And Suppresses Hepatocellular Carcinoma Induced In Rats Appl Biochem Biotechnol. 2023 Mar;195(3):1656-1674. PMID: 36367620", "BibTeX": "@article{36367620, title={Simvastatin Induces Apoptosis And Suppresses Hepatocellular Carcinoma Induced In Rats}, author={Elleithi YA and El-Gayar AM and Amin MN}, journal={Appl Biochem Biotechnol}, volume={195}, number={3}, pages={1656-1674}}"}}, {"_id": "35830548", "pmid": 35830548, "title": "Simvastatin is Efficacious in Treating Cirrhosis: A Meta-analysis.", "journal": "J Clin Gastroenterol", "authors": ["Zhang H", "Zhang Q", "Li S", "Xie B"], "date": "2022-09-01T00:00:00Z", "doi": "10.1097/MCG.0000000000001732", "meta_date_publication": "2022 Sep 1", "meta_volume": "56", "meta_issue": "8", "meta_pages": "e303-e312", "score": 50265.453, "text_hl": "Here, we performed a meta-analysis to evaluate the clinical efficacy of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver cirrhosis@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Zhang H, Zhang Q, Li S, Xie B. Simvastatin is Efficacious in Treating Cirrhosis: A Meta-analysis. J Clin Gastroenterol. 2022 Sep 1;56(8):e303-e312. PMID: 35830548", "BibTeX": "@article{35830548, title={Simvastatin is Efficacious in Treating Cirrhosis: A Meta-analysis.}, author={Zhang H and Zhang Q and Li S and Xie B}, journal={J Clin Gastroenterol}, volume={56}, number={8}, pages={e303-e312}}"}}, {"_id": "35811365", "pmid": 35811365, "pmcid": "PMC9271712", "title": "Improved anti-fibrotic effects by combined treatments of simvastatin and NS-398 in experimental liver fibrosis models", "journal": "Korean J Intern Med", "authors": ["Kang SH", "Yim HJ", "Hwang JW", "Kim MJ", "Lee YS", "Jung YK", "Yim H", "Kim BH", "Park HC", "Seo YS", "Kim JH", "Yeon JE", "Um SH", "Byun KS"], "date": "2022-07-01T00:00:00Z", "doi": "10.3904/kjim.2021.138", "meta_date_publication": "2022 Jul", "meta_volume": "37", "meta_issue": "4", "meta_pages": "745-756", "score": 50264.79, "text_hl": "Improved anti-fibrotic effects by combined treatments of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_N_(2_cyclohexyloxy_4_nitrophenyl)methanesulfonamide @CHEMICAL_MESH:C080955 @@@NS-398@@@ in experimental @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver fibrosis@@@ models", "citations": {"NLM": "Kang SH, Yim HJ, Hwang JW, Kim MJ, Lee YS, Jung YK, Yim H, Kim BH, Park HC, Seo YS, Kim JH, Yeon JE, Um SH, Byun KS. Improved anti-fibrotic effects by combined treatments of simvastatin and NS-398 in experimental liver fibrosis models Korean J Intern Med. 2022 Jul;37(4):745-756. PMID: 35811365", "BibTeX": "@article{35811365, title={Improved anti-fibrotic effects by combined treatments of simvastatin and NS-398 in experimental liver fibrosis models}, author={Kang SH and Yim HJ and Hwang JW and Kim MJ and Lee YS and Jung YK and Yim H and Kim BH and Park HC and Seo YS and Kim JH and Yeon JE and Um SH and Byun KS}, journal={Korean J Intern Med}, volume={37}, number={4}, pages={745-756}}"}}, {"_id": "33204591", "pmid": 33204591, "pmcid": "PMC7653246", "title": "Successful treatment of lathosterolosis: A rare defect in cholesterol biosynthesis:A case report and review of literature", "journal": "JIMD Rep", "authors": ["Yaplito-Lee J", "Pai G", "Hardikar W", "Hong KM", "Pitt J", "Marum J", "Amor DJ"], "date": "2020-08-18T00:00:00Z", "doi": "10.1002/jmd2.12158", "meta_date_publication": "2020 Nov", "meta_volume": "56", "meta_issue": "1", "meta_pages": "14-19", "score": 50263.97, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ treatment resulted in lowering of plasma @CHEMICAL_lathosterol @CHEMICAL_MESH:C001521 @@@lathosterol@@@ levels, improvement in transaminitis, and @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver fibrosis@@@ grade, suggesting that children with this condition should be actively treated in order to prevent progression of @DISEASE_Liver_Diseases @DISEASE_MESH:D008107 @@@liver disease@@@.", "citations": {"NLM": "Yaplito-Lee J, Pai G, Hardikar W, Hong KM, Pitt J, Marum J, Amor DJ. Successful treatment of lathosterolosis: A rare defect in cholesterol biosynthesis:A case report and review of literature JIMD Rep. 2020 Nov;56(1):14-19. PMID: 33204591", "BibTeX": "@article{33204591, title={Successful treatment of lathosterolosis: A rare defect in cholesterol biosynthesis:A case report and review of literature}, author={Yaplito-Lee J and Pai G and Hardikar W and Hong KM and Pitt J and Marum J and Amor DJ}, journal={JIMD Rep}, volume={56}, number={1}, pages={14-19}}"}}, {"_id": "39908052", "pmid": 39908052, "title": "Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial.", "journal": "JAMA", "authors": ["Pose E", "Jiménez C", "Zaccherini G", "Campion D", "Piano S", "Uschner FE", "de Wit K", "Roux O", "Gananandan K", "Laleman W", "Solé C", "Alonso S", "Cuyàs B", "Ariza X", "Juanola A", "Ma AT", "Napoleone L", "Gratacós-Ginès J", "Tonon M", "Pompili E", "Sánchez-Delgado J", "Allegretti AS", "Morales-Ruiz M", "Carol M", "Pérez-Guasch M", "Fabrellas N", "Pich J", "Martell C", "Joyera M", "Domenech G", "Ríos J", "Torres F", "Serra-Burriel M", "Hernáez R", "Solà E", "Graupera I", "Watson H", "Soriano G", "Bañares R", "Mookerjee RP", "Francoz C", "Beuers U", "Trebicka J", "Angeli P", "Alessandria C", "Caraceni P", "Vargas VM", "Abraldes JG", "Kamath PS", "Ginès P", "LIVERHOPE Consortium"], "date": "2025-02-05T00:00:00Z", "doi": "10.1001/jama.2024.27441", "meta_date_publication": "2025 Feb 5", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50261.32, "text_hl": "Importance: There are no useful treatments to prevent the development of severe complications of @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver cirrhosis@@@. @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ and @CHEMICAL_Rifaximin @CHEMICAL_MESH:D000078262 @@@rifaximin@@@ have shown beneficial effects in @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver cirrhosis@@@. ", "citations": {"NLM": "Pose E, Jiménez C, Zaccherini G, Campion D, Piano S, Uschner FE, de Wit K, Roux O, Gananandan K, Laleman W, Solé C, Alonso S, Cuyàs B, Ariza X, Juanola A, Ma AT, Napoleone L, Gratacós-Ginès J, Tonon M, Pompili E, Sánchez-Delgado J, Allegretti AS, Morales-Ruiz M, Carol M, Pérez-Guasch M, Fabrellas N, Pich J, Martell C, Joyera M, Domenech G, Ríos J, Torres F, Serra-Burriel M, Hernáez R, Solà E, Graupera I, Watson H, Soriano G, Bañares R, Mookerjee RP, Francoz C, Beuers U, Trebicka J, Angeli P, Alessandria C, Caraceni P, Vargas VM, Abraldes JG, Kamath PS, Ginès P, LIVERHOPE Consortium. Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial. JAMA. 2025 Feb 5;():. PMID: 39908052", "BibTeX": "@article{39908052, title={Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial.}, author={Pose E and Jiménez C and Zaccherini G and Campion D and Piano S and Uschner FE and de Wit K and Roux O and Gananandan K and Laleman W and Solé C and Alonso S and Cuyàs B and Ariza X and Juanola A and Ma AT and Napoleone L and Gratacós-Ginès J and Tonon M and Pompili E and Sánchez-Delgado J and Allegretti AS and Morales-Ruiz M and Carol M and Pérez-Guasch M and Fabrellas N and Pich J and Martell C and Joyera M and Domenech G and Ríos J and Torres F and Serra-Burriel M and Hernáez R and Solà E and Graupera I and Watson H and Soriano G and Bañares R and Mookerjee RP and Francoz C and Beuers U and Trebicka J and Angeli P and Alessandria C and Caraceni P and Vargas VM and Abraldes JG and Kamath PS and Ginès P and LIVERHOPE Consortium}, journal={JAMA}}"}}, {"_id": "40195910", "pmid": 40195910, "title": "Ultrasound-Mediated Biomimetic Microbubbles Effectively Reverse LSECs Capillarization and Exert Antiplatelet Therapy in Liver Fibrosis.", "journal": "Adv Healthc Mater", "authors": ["Deng H", "Ye H", "Xiao H", "You Y", "Miao X", "Zhang W", "Leng Y", "Zheng R", "Shuai X", "Ren J", "Yin T"], "date": "2025-04-08T00:00:00Z", "doi": "10.1002/adhm.202500196", "meta_date_publication": "2025 Apr 8", "meta_volume": "", "meta_issue": "", "meta_pages": "e2500196", "score": 50261.07, "text_hl": "This study demonstrates the strong therapeutic efficacy of the multifunctional MBs integrating @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Sim@@@ and PLT against @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver fibrosis@@@, which highlights a great potential for effectively managing this intractable chronic disease.", "citations": {"NLM": "Deng H, Ye H, Xiao H, You Y, Miao X, Zhang W, Leng Y, Zheng R, Shuai X, Ren J, Yin T. Ultrasound-Mediated Biomimetic Microbubbles Effectively Reverse LSECs Capillarization and Exert Antiplatelet Therapy in Liver Fibrosis. Adv Healthc Mater. 2025 Apr 8;():e2500196. PMID: 40195910", "BibTeX": "@article{40195910, title={Ultrasound-Mediated Biomimetic Microbubbles Effectively Reverse LSECs Capillarization and Exert Antiplatelet Therapy in Liver Fibrosis.}, author={Deng H and Ye H and Xiao H and You Y and Miao X and Zhang W and Leng Y and Zheng R and Shuai X and Ren J and Yin T}, journal={Adv Healthc Mater}, pages={e2500196}}"}}, {"_id": "38128755", "pmid": 38128755, "title": "Combined quercetin and simvastatin attenuate hepatic fibrosis in rats by modulating SphK1/NLRP3 pathways.", "journal": "Life Sci", "authors": ["Salama YA", "Hassan HM", "El-Gayar AM", "Abdel-Rahman N"], "date": "2024-01-15T00:00:00Z", "doi": "10.1016/j.lfs.2023.122349", "meta_date_publication": "2024 Jan 15", "meta_volume": "337", "meta_issue": "", "meta_pages": "122349", "score": 50255.797, "text_hl": "Combined @CHEMICAL_Quercetin @CHEMICAL_MESH:D011794 @@@quercetin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ attenuate @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@hepatic fibrosis@@@ in @SPECIES_10116 @@@rats@@@ by modulating @GENE_SPHK1 @GENE_170897 @@@SphK1@@@/@GENE_NLRP3 @GENE_287362 @@@NLRP3@@@ pathways.", "citations": {"NLM": "Salama YA, Hassan HM, El-Gayar AM, Abdel-Rahman N. Combined quercetin and simvastatin attenuate hepatic fibrosis in rats by modulating SphK1/NLRP3 pathways. Life Sci. 2024 Jan 15;337():122349. PMID: 38128755", "BibTeX": "@article{38128755, title={Combined quercetin and simvastatin attenuate hepatic fibrosis in rats by modulating SphK1/NLRP3 pathways.}, author={Salama YA and Hassan HM and El-Gayar AM and Abdel-Rahman N}, journal={Life Sci}, volume={337}, pages={122349}}"}}, {"_id": "37213003", "pmid": 37213003, "title": "Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients.", "journal": "Dig Dis Sci", "authors": ["Muñoz AE", "Pollarsky F", "Marino M", "Cartier M", "Míguez C", "Rodger EG", "Vázquez H", "Salgado P", "Álvarez D", "Romero G"], "date": "2023-05-22T00:00:00Z", "doi": "10.1007/s10620-023-07969-3", "meta_date_publication": "2023 May 22", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50255.52, "text_hl": "Finally, admissions for @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@cirrhosis complications@@@ decreased in CPc AEST versus CPc B/C (P = 0.017). ", "citations": {"NLM": "Muñoz AE, Pollarsky F, Marino M, Cartier M, Míguez C, Rodger EG, Vázquez H, Salgado P, Álvarez D, Romero G. Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients. Dig Dis Sci. 2023 May 22;():. PMID: 37213003", "BibTeX": "@article{37213003, title={Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients.}, author={Muñoz AE and Pollarsky F and Marino M and Cartier M and Míguez C and Rodger EG and Vázquez H and Salgado P and Álvarez D and Romero G}, journal={Dig Dis Sci}}"}}, {"_id": "37381761", "pmid": 37381761, "title": "Protective effects of statins on the incidence of NAFLD-related decompensated cirrhosis in T2DM.", "journal": "Liver Int", "authors": ["Wu SY", "Chen WM", "Chiang MF", "Lo HC", "Wu MS", "Lee MC", "Soong RS"], "date": "2023-06-29T00:00:00Z", "doi": "10.1111/liv.15656", "meta_date_publication": "2023 Jun 29", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50243.312, "text_hl": "RESULTS: A higher cumulative dose and specific types of statins, namely @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@, @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@, @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Fluvastatin @CHEMICAL_MESH:D000077340 @@@fluvastatin@@@, reduced the risk of @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@DLC@@@ in patients with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@. ", "citations": {"NLM": "Wu SY, Chen WM, Chiang MF, Lo HC, Wu MS, Lee MC, Soong RS. Protective effects of statins on the incidence of NAFLD-related decompensated cirrhosis in T2DM. Liver Int. 2023 Jun 29;():. PMID: 37381761", "BibTeX": "@article{37381761, title={Protective effects of statins on the incidence of NAFLD-related decompensated cirrhosis in T2DM.}, author={Wu SY and Chen WM and Chiang MF and Lo HC and Wu MS and Lee MC and Soong RS}, journal={Liver Int}}"}}, {"_id": "24098525", "pmid": 24098525, "pmcid": "PMC3788732", "title": "Simvastatin Ameliorates Liver Fibrosis via Mediating Nitric Oxide Synthase in Rats with Non-Alcoholic Steatohepatitis-Related Liver Fibrosis", "journal": "PLoS One", "authors": ["Wang W", "Zhao C", "Zhou J", "Zhen Z", "Wang Y", "Shen C"], "date": "2013-10-02T00:00:00Z", "doi": "10.1371/journal.pone.0076538", "meta_date_publication": "2013", "meta_volume": "8", "meta_issue": "10", "meta_pages": "e76538", "score": 50086.098, "text_hl": "We aimed to clarify the relationship between @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver fibrosis@@@ both in vivo and in vitro.", "citations": {"NLM": "Wang W, Zhao C, Zhou J, Zhen Z, Wang Y, Shen C. Simvastatin Ameliorates Liver Fibrosis via Mediating Nitric Oxide Synthase in Rats with Non-Alcoholic Steatohepatitis-Related Liver Fibrosis PLoS One. 2013;8(10):e76538. PMID: 24098525", "BibTeX": "@article{24098525, title={Simvastatin Ameliorates Liver Fibrosis via Mediating Nitric Oxide Synthase in Rats with Non-Alcoholic Steatohepatitis-Related Liver Fibrosis}, author={Wang W and Zhao C and Zhou J and Zhen Z and Wang Y and Shen C}, journal={PLoS One}, volume={8}, number={10}, pages={e76538}}"}}]}